Study of cytokine control using the CRRT after open-heart surgery

Study of cytokine control using the CRRT after open-heart surgery - Cytokine contorol using the CRRT after open-heart surgery

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000013124

Enrollment

Registered

2014-02-13

Start date

2014-02-13

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Valvular disease of the heart Cardiovascular disease

Interventions

CRRT with PMMA membrane CRRT with cellulose triacetate membrane

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who underwent open-heart surgery with cardio pulmonaly bypass

Exclusion criteria

Exclusion criteria: Patients who has been indicated in CRRT after it passes 6 or more hours after entering ICU

Design outcomes

Primary

Measure	Time frame
Leukocyte, CRP, AST, ALT, GTP, Bilirubin, LDH, serum creatinine, BUN, IL-1, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12, IL-13, IL-17, G-CSF, GM-CSF, TNF, IFN, MCP-1, MIP-1 Hemodynamics(arterial blood pressure, pulmonaly blood pressure, cemtral venous puressure , CI) Measurement points are before CPB, aafter CPB, entering ICU, 6h after entering ICU, 12h after entering ICU	—

Countries

Japan

Contacts

Public ContactMatsushita Satoshi

Juntendo University Department of Cardiothoracic Surgery

saty-m@juntendo.ac.jp03-3813-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026